Displaying 1 - 12 of 15
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
1

Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
Cirrhosis & Complications
6

Grifols: The journey of a cirrhotic patient: when Albumin plays a key role - ILC 2022

View
Cirrhosis & Complications
6

Grifols: The journey of a cirrhotic patient: when Albumin plays a key role - ILC 2022

View
Cirrhosis & Complications
6

Grifols: The journey of a cirrhotic patient: when Albumin plays a key role - ILC 2022

View
Cirrhosis & Complications
6

Grifols: The journey of a cirrhotic patient: when Albumin plays a key role - ILC 2022

View
Cirrhosis & Complications
6

Grifols: The journey of a cirrhotic patient: when Albumin plays a key role - ILC 2022

View
Cirrhosis & Complications
6

Grifols: The journey of a cirrhotic patient: when Albumin plays a key role - ILC 2022

View
Displaying 1 - 12 of 15